These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22342023)

  • 1. False-positive hepatitis B serology following IVIG therapy: forgotten but not gone!!
    Benton E; Iqbal K; Wade P; Wong T; Aarons E; Groves R
    J Am Acad Dermatol; 2012 Mar; 66(3):e123-4. PubMed ID: 22342023
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin.
    Campos M; Silvente C; Lecona M; Suárez R; Lázaro P
    Clin Exp Dermatol; 2006 Jan; 31(1):71-3. PubMed ID: 16309488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia.
    Arnold DM; Crowther MA; Meyer RM; Carruthers J; Ditomasso J; Heddle NM; McLeod A; Kelton JG
    Transfusion; 2010 Dec; 50(12):2577-81. PubMed ID: 20576011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidermolysis bullosa acquisita: literature review].
    Le Roux-Villet C; Prost-Squarcioni C
    Ann Dermatol Venereol; 2011 Mar; 138(3):228-46. PubMed ID: 21397153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidermolysis bullosa acquisita. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Prost-Squarcioni C; Ingen-Housz-Oro S; Joly P; Bernard P; Bedane C;
    Ann Dermatol Venereol; 2011 Mar; 138(3):274-9. PubMed ID: 21397160
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of refractory epidermolysis bullosa acquisita with intravenous immunoglobulin and dapsone.
    McLawhorn JM; Johnson AW; Kim KH; Addis K
    Cutis; 2019 Aug; 104(2):E20-E21. PubMed ID: 31603972
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab.
    Schmidt E; Benoit S; Bröcker EB; Zillikens D; Goebeler M
    Arch Dermatol; 2006 Feb; 142(2):147-50. PubMed ID: 16490841
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.
    Wallet-Faber N; Franck N; Batteux F; Mateus C; Gilbert D; Carlotti A; Avril MF; Dupin N
    Dermatology; 2007; 215(3):252-5. PubMed ID: 17823525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory epidermolysis bullosa acquisita: successful treatment with rituximab.
    Saha M; Cutler T; Bhogal B; Black MM; Groves RW
    Clin Exp Dermatol; 2009 Dec; 34(8):e979-80. PubMed ID: 20055876
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidermolysis bullosa acquisita and hepatitis C].
    Thiery S; Misery L; Chossegros P; Kanitakis J; Ghohestani R; Forestier JY; Trepo C; Faure M; Claudy A
    Ann Dermatol Venereol; 1998 Apr; 125(4):264-7. PubMed ID: 9747265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermolysis bullosa acquisita: correlation of IgE levels with disease activity under successful betamethasone/dapsone combination therapy.
    Miyake H; Morishima Y; Komai R; Hashimoto T; Kishimoto S
    Acta Derm Venereol; 2001; 81(6):429. PubMed ID: 11859948
    [No Abstract]   [Full Text] [Related]  

  • 12. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive intercellular indirect immunofluorescence test due to anti-blood group antibodies in a patient with epidermolysis bullosa acquisita.
    Li W; Zhao X; Shi R; Wang X; Zheng J
    Int J Dermatol; 2011 Apr; 50(4):462-6. PubMed ID: 21413961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermolysis bullosa acquisita associated with psoriasis.
    Kabashima R; Hino R; Bito T; Kabashima K; Nakamura M; Bungo O; Hashimoto T; Tokura Y
    Acta Derm Venereol; 2010 May; 90(3):314-6. PubMed ID: 20526561
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal Pseudomona pneumonia following rituximab therapy in a patient with epidermolysis bullosa acquisita.
    Mercader P; Rodenas JM; Peña A; Mascaro JM
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1141-2. PubMed ID: 17714160
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).
    Niedermeier A; Eming R; Pfütze M; Neumann CR; Happel C; Reich K; Hertl M
    Arch Dermatol; 2007 Feb; 143(2):192-8. PubMed ID: 17309999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems of an automated testing system for hepatitis B.
    Cameron SO; Stewart J; Davidson M; Ho-Yen D
    Commun Dis Public Health; 2000 Jun; 3(2):141-2. PubMed ID: 10902261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
    Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
    Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation?
    Burger J; Gmür J; Bruckner-Tuderman L
    Bone Marrow Transplant; 1992 Feb; 9(2):139-41. PubMed ID: 1571712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita.
    Tayal U; Burton J; Dash C; Wojnarowska F; Chapel H
    Clin Immunol; 2008 Dec; 129(3):518-9. PubMed ID: 18848500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.